Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
Clinical trial NCT03468296 · UNKNOWN
Trial details
- NCT number
- NCT03468296
- Sponsor
- Tennessee Retina
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2018-10-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.